Shares of Aurobindo Pharma gained in Monday trading after it decided to terminate an agreement to acquire a majority stake in Cronus Pharma. The acquisition proposal along with the company's weak June quarter results riled investors. The stock lost a fifth of its value in less than 10 trading days after the announcement of the acquisition. The Rs 420 crore acquisition amounts to less than 8 percent of Aurobindo’s FY21 net earnings and is unlikely to have made a major dent to its finances. However, the...
Moneycontrol Pro Panorama | Budget 2023: Bonds jump in joy, stocks sulk
Feb 3, 2023 / 02:02 PM IST
In today’s edition of Moneycontrol Pro Panorama: Old Pension Scheme is not a gamechanger, bitcoin makes a comeback, big firms st...Read Now
To read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Access to 230+ exclusive stories per month from our editorial and Experts
Have a Global edge with access to content from world renowned experts and journalist
Access to 40+ weekly investment ideas including 4 daily technical calls
Exclusive access to live webinars from market experts on trading and investment strategies
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers